[1] 易恬,马兰,杨晓玲,等.输卵管手术对IVF-ET卵巢反应性及妊娠结局影响的研究[J].实用妇产科杂志,2016,32(8):597-601. [2] 田东梅,李亨利,朱明辉,等.卵巢储备正常者COH不同阶段添加高纯度人绝经期促性腺激素对IVF-ET结局的影响[J].生殖与避孕,2016,36(9):769-773. [3] Nojavan S, Bidarmanesh T, Mohammadi A, et al. Electromembrane extraction of gonadotropin-releasing hormone agonists from plasma and wastewater samples[J]. Electrophoresis, 2016, 37(5-6):826-833. [4] 杜惠,张文静,朱旻,等.促性腺激素释放激素激动剂超长方案提高中重度子宫内膜异位症患者辅助生殖技术妊娠率[J].第二军医大学学报,2017,38(7):852-856. [5] 戚静宜,刘格琳,周晓景,等.体外受精-胚胎移植中口服避孕药对非排卵障碍患者治疗的影响[J].重庆医学,2017,46(16):2258-2260. [6] 吴洪波,李柳铭,李慕军,等.IVF-ET中卵巢低反应患者拮抗剂方案中应用生长激素的研究[J].生殖与避孕,2016,36(5):416-420. [7] Lee HS, Yoon JS, Roh JK, et al. Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty[J]. Endocrine, 2016, 54(2):1-7. [8] 刘星妍,杨蕴洁,唐传玲,等.促排卵启动时间对子宫内膜异位症妇女体外受精妊娠结局的影响[J].中华生殖与避孕杂志,2017,37(8):633-637. [9] 姜永辉,孔伟,刘燕,等.3种促排卵方案对子宫内膜异位症患者妊娠结局的影响分析[J].现代妇产科进展,2016,25(7):535-537. [10] Penson DF. Re: Comparison of gonadotropin-releasing hormone agonists and orchiectomy: effects of androgen-deprivation therapy[J]. J Urology, 2016, 196(1):104-106. [11] 范文,李东娅,杨晓玲,等.生长激素在超重及肥胖不孕患者IVF-ET中的应用价值[J].实用妇产科杂志,2016,32(10):774-777. [12] 周薇,雷磊.固胎汤对反复胚胎移植失败患者体外受精胚胎移植妊娠结局的影响[J].中医杂志,2017,58(2):133-136. [13] 陈攀宇,贾磊,李婷婷,等.拮抗剂方案中应用促性腺激素释放激素激动剂联合人绒毛膜促性腺激素诱导卵泡成熟的结局分析[J].生殖与避孕,2016,36(12):986-991
2019, Vol. 26 
